UNSPSC 85877409: Fluoroscopy of right kidney, ureter and bladder

This classification denotes the group of activities that yields a imaging intervention or procedure to fluoroscopy of right kidney, ureter and bladderfluoroscopy of right kidney, ureter and bladder. This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code BT1DZZZ

UNSPSC 85877409 Fluoroscopy of right kidney, ureter and bladder is a Commodity code that shows limited direct relevance to recent state and local procurement activity. The code describes a specific diagnostic imaging procedure, yet the recent opportunities tagged to it span enterprise health system infrastructure, school district special education services, and temporary clinical staffing — none of which align with the nominal scope of individual fluoroscopy studies. San Mateo Medical Center's RFP for a Diagnostic Imaging PACS system (due October 21, 2026) addresses radiology infrastructure and data migration rather than the performance of fluoroscopy procedures themselves; the Santa Clara Health System's temporary health professional staffing RFQ (due October 7, 2026) includes diagnostic imaging and radiology categories but as part of a broad ancillary clinical pool, not fluoroscopy-specific work; and Birdville Independent School District's special education services solicitation is unrelated to medical imaging. The mismatch suggests either tagging inconsistency or that this code captures only a narrow slice of actual state and local imaging procurement.

Geographic activity shows California (San Mateo County, Santa Clara County) and Texas (Tarrant County) represented in the limited recent record. No dominant repeat buyer or concentration pattern emerges from the three opportunities. Absent direct alignment between the code's nominal scope and the work being solicited, and given the sparse recent activity tagged to this Commodity code, pursuit is unlikely to yield productive leads unless your firm targets health system infrastructure contracts (PACS, storage, integration services) rather than individual fluoroscopy procedures or imaging studies themselves.